© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
Moderna has a patent that acknowledges RNA is preferable to DNA in vaccines due to risks of insertional mutagenesis, which might activate oncogenes or inhibit tumor suppressor genes, Dr. Malone explained.





